Top Markets
#1 Cortex Cortex +173.67%
#2 GEKKO GEKKO +53.94%
#3 Helium Helium +32.96%
#4 Audiera Audiera +20.48%
#5 ADO Protocol ADO Protocol +17.96%
#6 Ontology Gas Ontology Gas +15.92%
#7 Pons Pons +15.26%
#8 COTI COTI +14.32%
#9 o1.exchange o1.exchange +13.62%
#10 TENDIES TENDIES +9.27%
Coin of the day
Cortex Cortex
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Classifica tra le azioni #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Prezzo delle azioni
$59.98
Ultima sincronizzazione: 2024-12-13
Capitalizzazione di mercato
$1.22B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Longboard Pharmaceuticals, Inc. (LBPH)

Categoria

Healthcare
Utile per Longboard Pharmaceuticals, Inc. (LBPH)
Utile nel Sep 2024 TTM: $-76.34M
Secondo gli ultimi rapporti finanziari di Longboard Pharmaceuticals, Inc., gli utili attuali della società sono $-76.34M. Nel 2022, la società ha registrato un utile di $-43.95M, una diminuzione rispetto a agli utili del 2021, che erano di $-27.80M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Longboard Pharmaceuticals, Inc. dal 2020 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $-76.34M 40.28%
2023 $-54.42M 23.84%
2022 $-43.95M 58.09%
2021 $-27.80M 93.03%
2020 $-14.40M 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -7,009.38%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -2,655.08%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B 5,160.66%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B 3,943.54%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH